SavedAdd your journal

Journals / İnfeksiyon Dergisi / 2006 / Cilt: 20 - Sayı: 3

Distribution of agents of vaginal infection in pregnants

Gebelerde saptanan vajinal infeksiyon etkenlerinin dağılımı

Gönül AKSU
Ali HABERAL
Arzu KARADUMAN
Doğruman Funda AL
Pages
171–175
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

During the routine examination of pregnants examining the vaginal wipe samples is essential in order to determine the type of treatment required to prevent the possible complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The vaginal infections among pregnant women are quite important in terms of maternal and neonatal complications.
📊
Key Findings & Data:The vaginal wipe samples from 229 pregnant women were examined, and it was observed that 42.3% of the subjects had agents for vaginal infection.
💡
Conclusion & Impact:During the routine examination of pregnants examining the vaginal wipe samples is essential in order to determine the type of treatment required to prevent the possible complications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The vaginal infections among pregnant women are quite important in terms of maternal and neonatal complications. The purpose of this study was to determine the distribution of causative agents of vaginitis in pregnants. The vaginal wipe samples from 229 pregnant women were examined, and it was observed that 42.3% of the subjects had agents for vaginal infection. The agent distribution was as follows: in 34% Candida spp., in 3.4% Trichomonas vaginalis and 0.4% Group B streptococci. Of the pregnants 11.9% had bacterial vaginosis (BV). The combination of BV and Candida was observed in 6.6%, while the combination of BV and TV was in 0.4%. During the routine examination of pregnants examining the vaginal wipe samples is essential in order to determine the type of treatment required to prevent the possible complications.

Özet

Gebelerde meydana gelen vajinal infeksiyonlar, maternal ve neonatal komplikasyonlar açısından önem taşımaktadır. Bu çalışmanın amacı, gebelerde görülen vajinal infeksiyonların etkenlerini saptamak idi. Toplam 229 gebe kadının vajinal sürüntü örnekleri incelenmiş ve olguların %42.3'ünde vajinal infeksiyon etkeni saptanmıştır. Vajinal akıntı örneklerinde %34 Candida spp., %3.4 Trichomonas vaginalis (TV) ve %0.4 oranında GB Grubu streptokok belirlenmiş; incelenen gebelerin % 11.9'unda ise bakteriyel vajinoz (BV) tanımlanmıştır. Bakteriyel vajinoz ile Candida birlikteliği %6.6, BV ile TV birlikteliği ise %0.4 oranında saptanmıştır. Gebelerin rutin muayeneleri sırasında vajinal sürüntü örneklerinin incelenmesinin, oluşabilecek komplikasyonları önlemek amacıyla gerekli tedavi yaklaşımlarının uygulanmasını sağlaması açısından önem taşıyacağı sonucuna varılmıştır.

🔖

Cite This Article

AKSU, G., HABERAL, A., KARADUMAN, A., AL, D. F. (2022). Distribution of agents of vaginal infection in pregnants. İnfeksiyon Dergisi, Cilt: 20 - Sayı: 3, 171–175. https://ajindex.com/articles/546415

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Marai W. Lower genital tract infections among pregnant women: a review. East Afr Med J 2001; 78: 581-5
  2. Thorsen P, Vogel I, Olsen J, et al. Bacterial vaginosis in early pregnancy is associated with low birth weight and small for gestational age, but not with spontaneous preterm birth: A population-based study on Danish women. J Matern Fetal Neonatal Med 2006; 19: 1-7
  3. Amsel R, Toton PA, Spiegel CA, Chen KCS, Eschenbach DA, Holmes KK. Nonspecific vaginitis: Diagnostic criteria and microbial and apidemiologic associations. Am J Med 1983; 74: 14-22
  4. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991; 29: 297-301
  5. Centers for Disease Control and Prevention. Guidelines for treatment of STDs. Mortal Morbid Wkly Rep 1998: 47: 1-111
  6. McGregor JA, French Jl. Bacterial vaginosis in pregnancy. Obstet Gynecol Surv 2000; 55 (Suppl 1): 1-19
  7. Carr PL, Felsenstein D, Friedman RH. Evaluation and management of vaginitis. J Gen Intern Med 1998; 13: 335-46
  8. Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA. Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 1998; 178: 374-80
  9. Ferrer J. Vaginal candidosis: epidemiological and etiological factors. Intern J Gynecol Obset 2000; 71: 21-7
  10. Lanchares JL, Hernandez ML. Recurrent vaginal candidiasis changes in etiopathogenical patterns. Intern J Gynecol Obstet 2000; 71: 29-35
  11. Chen KCS, Forsth PS, Buchanan TM, Holmes KK. Amine content of vaginal fluid from untreated and treated patients with nonspecific vaginitis. J Clin Invest 1979; 63: 828-35
  12. Martius J, Eschenbach DA. The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity: A review. Arch Gynecol Obstet 1990; 274: 1-13
  13. Donders GGG, Vereecken A, Eugene B, Dekeersmaecker A, Salembier G, Spitz B. Definition of atype of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 2002; 109: 34-43
  14. McGregor JA, Lawellin D, Franco-Buff A, Todd JK, Makowski EL. Protease production by microorganisms associated with reproductive tract infection. Am J Obstet Gynecol 1986; 154: 109-14
  15. Morales WJ, Schorr S, Albritton J. Effect of metranidazole in patients with term birth in preceding pregnancy and bacterial vaginosis: a placebo- controlled,